Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues 2025
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Anticancer Research
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Anticancer Research

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues 2025
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Visit us on Facebook
  • Follow us on Linkedin
LetterLetter to the Editor
Open Access

Novel Insights in Genetic Variant Classification

ANTHOULA CHATZIKYRIAKIDOU
Anticancer Research April 2024, 44 (4) 1799-1802; DOI: https://doi.org/10.21873/anticanres.16980
ANTHOULA CHATZIKYRIAKIDOU
Laboratory of Medical Biology – Genetics, Faculty of Medicine, School of Health Sciences, Aristotle University, Thessaloniki, Greece
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: chatzikyra@auth.gr
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading
Key Words:
  • Single nucleotide polymorphism
  • variant classification
  • pathogenic
  • VUS
  • benign
  • dominant
  • recessive
  • genetic heterogeneity
  • incomplete penetrance
  • Mendelian inheritance
  • Complex inheritance
  • human disease

Genes which correlate with dominant inherited diseases are mainly found in low single nucleotide polymorphism (SNP) hotspot regions of human chromosomes, whereas genes that correlate with recessive inherited diseases are mainly found in dense SNP hotspot regions along human chromosomes (1). Therefore, SNPs’ haplotypes are expected to play a role in allele-specific expression and to affect the principles of Mendelian or Complex inheritance (1).

In continuation of this research, I am currently focusing on chromosome regions identified by tag SNPs. These tag SNPs were identified using a metaSNP approach, employing a pairwise-linkage disequilibrium (LD) based Tagger on datasets from the 1000 Genomes Project (this article is under CC BY 4.0 license) (2). A tag SNP is a representative SNP in a region of the genome characterized by high LD that represents a group of SNPs called a haplotype. According to a recent study, tag SNPs among human populations can be considered representative of the human genome (3). Therefore, tag SNPs are highly informative not only within populations of the same continental group but also among reference populations (Europeans, Middle Eastern, and Central/South Asian) and of more distant and differentiated populations (Oceania, Americas) (3).

Taking into account that a disease mutation is more likely to occur on a common haplotype (4) and the fact that tag SNP variants reported by Elmas et al. concern a small set of around 15-20 tag SNPs per chromosome, which represent the genetic diversity of thousands of multi-population samples (2), I tried to explore whether the mode of inheritance within the most representative haplotypes captured by the tag SNPs across autosomal chromosomes aligns with the results of my previous study (1). For this reason, I retrieved the genes containing or being adjacent to each reported tag SNP of autosomal chromosomes, as identified by metaSNP in the 1000 Genomes Project genotypes by Elmas et al. in supplementary table S5 of ref (2). For the above inquiry, I used the NCBI Genome Data Viewer (5) based on genome assembly GRCh37/hg19. Then, the identified genes by this analysis were searched in OMIM database (6) for their association with a specific autosomal dominant (AD) or autosomal recessive (AR) disease.

In total, 462 tag SNPs have been reported across human autosomal chromosomes (2), with the vast majority being intronic or intergenic variants (2). In chromosomal regions related with these tag SNPs, I retrieved 19 AD and 37 AR OMIM diseases (Table I). According to my previous study, the chromosomes were classified in relation to SNP hotspot regions density from lowest to highest as: 13, 1, 14, 21, 18, 2, 20, 5, 12, 15, 17, 6, 10, 3, 11, 22, 4, 7, 9, 19, 8, and 16 (1). Knowing that AD and AR diseases are differentially presented across chromosomes due to differences in the frequencies of SNP hotspot regions, which can affect the mode of inheritance (1), non-parametric tests (SPSS Inc., Chicago, IL, USA) were performed to examine differences in disease distribution among chromosome regions trapped by the tag SNPs. One sample Kolmogorov-Smirnov test revealed that there is statistically significant difference in the number of AD diseases (p<0.001) and AR diseases (p<0.001) among chromosomes. Furthermore, the Wilcoxon signed-rank test indicated that there is a marginally significant difference in the number of both AD and AR diseases among chromosomes (p=0.047). These findings align with expectations, as autosomal chromosomes with different densities of SNP hotspot regions affect the number of inherited diseases across them (1), a phenomenon reflected also in chromosomal regions characterized by captured diversity from tag SNPs.

View this table:
  • View inline
  • View popup
Table I.

Tag SNPs across autosomal chromosomes and related OMIM diseases.

It may appear strange to observe peaks of AD disorders on chromosome 16 (n=4) and 19 (n=4) (Figure 1), because these chromosomes, known for their highest density of SNP hotspots (1), would not typically harbor such high numbers of AD disorders. One possible explanation is that mutations related to AD diseases corresponding to the tag SNPs of chromosome 16 and 19 are evolutionary novel de novo “dominant” deleterious variants, which have not yet been removed from the population genomic respiratory (1). It is worth mentioning that chromosomes 16 and 19 have been characterized as having significantly high local de novo mutation (DNM) rate, probably due to atypical mutational processes (7). Furthermore, chromosomes 8, 9, 16, and 19 have been reported to have the highest local DNM rates (7), which is in accordance with my previous classification of chromosomes according to their SNP hotspot density, also noted as being the highest polymorphic (1). I repeated the Wilcoxon signed-rank test without including the data of AD and AR diseases of chromosomes 8, 9, 16, and 19 in order to exclude their high DNM rate bias from the analysis and to isolate the possible effect of SNP hotspots. The analysis revealed that there is a highly significant difference in the number of both AD and AR diseases among the remaining chromosomes (p=0.005).

Figure 1.
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 1.

The number of autosomal dominant (AD) and autosomal recessive (AR) diseases in chromosomes’ regions captured by tag SNPs.

In conclusion, the present short report underscores the significance of haplotypic data of SNPs in influencing Mendelian or Complex mode of inheritance and their potential use to explain inconsistencies in variant classification. Despite the significance of sophisticated analysis and interpretation methods developed for variant classification based on evidence from population, computational, functional, and segregation data (8), variant classification often exhibits inconsistencies among scientists (9, 10). The American College of Medical Genetics and Genomics (ACMG)-recommended five variant classification categories (pathogenic, likely pathogenic, uncertain significance, likely benign, and benign) (11). The new developed Artificial Intelligence (AI) algorithms should make use of SNP haplotypic phase as an evolutionary genetic clock and informative index of crucial chromosomes regions, since the generation and expression of genetic variants in a specific genomic locus is affected by genomic features of the surrounding region such as adjacent nucleotide context, histone and chromatin modifications, DNA replication timing, chromatin recombination, and de novo mutation rates (1, 7, 12). Therefore, high SNP hotspot loci not only point out chromosomal regions susceptible to mutability and specific mutagenic mechanisms, but also, as I have previously presented, they can also affect mutation expression (1, 12). By leveraging the wealth of knowledge regarding human genome features, AI algorithms could be the key step toward achieving a more uniform variant classification and shed light on previously elusive heritability factors.

Footnotes

  • Conflicts of Interest

    The Author declares that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

  • Received January 10, 2024.
  • Revision received February 1, 2024.
  • Accepted February 2, 2024.
  • Copyright © 2024 International Institute of Anticancer Research (Dr. George J. Delinasios), All rights reserved.

This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY-NC-ND) 4.0 international license (https://creativecommons.org/licenses/by-nc-nd/4.0).

References

  1. ↵
    1. Chatzikyriakidou A
    : SNPs as stochastic oscillators in inheritance of human diseases. Anticancer Res 44(1): 107-115, 2024. DOI: 10.21873/anticanres.16793
    OpenUrlAbstract/FREE Full Text
  2. ↵
    1. Elmas A,
    2. Ou Yang TH,
    3. Wang X,
    4. Anastassiou D
    : Discovering genome-wide tag SNPs based on the mutual information of the variants. PLoS One 11(12): e0167994, 2016. DOI: 10.1371/journal.pone.0167994
    OpenUrlCrossRefPubMed
  3. ↵
    1. González-Neira A,
    2. Ke X,
    3. Lao O,
    4. Calafell F,
    5. Navarro A,
    6. Comas D,
    7. Cann H,
    8. Bumpstead S,
    9. Ghori J,
    10. Hunt S,
    11. Deloukas P,
    12. Dunham I,
    13. Cardon LR,
    14. Bertranpetit J
    : The portability of tagSNPs across populations: a worldwide survey. Genome Res 16(3): 323-330, 2006. DOI: 10.1101/gr.4138406
    OpenUrlAbstract/FREE Full Text
  4. ↵
    1. Tzeng JY,
    2. Devlin B,
    3. Wasserman L,
    4. Roeder K
    : On the identification of disease mutations by the analysis of haplotype similarity and goodness of fit. Am J Hum Genet 72(4): 891-902, 2003. DOI: 10.1086/373881
    OpenUrlCrossRefPubMed
  5. ↵
    Human Genome Assembly GRCh37. Available at: https://www.ncbi.nlm.nih.gov/grc/human/data?asm=GRCh371 [Last accessed on January 3, 2024]
  6. ↵
    Online Mendelian Inheritance in Man, OMIM®. McKusick-Nathans Institute of Genetic Medicine, Johns Hopkins University (Baltimore, MD). Available at: https://omim.org/ [Last accessed on January 3, 2024]
  7. ↵
    1. Kessler MD,
    2. Loesch DP,
    3. Perry JA,
    4. Heard-Costa NL,
    5. Taliun D,
    6. Cade BE,
    7. Wang H,
    8. Daya M,
    9. Ziniti J,
    10. Datta S,
    11. Celedón JC,
    12. Soto-Quiros ME,
    13. Avila L,
    14. Weiss ST,
    15. Barnes K,
    16. Redline SS,
    17. Vasan RS,
    18. Johnson AD,
    19. Mathias RA,
    20. Hernandez R,
    21. Wilson JG,
    22. Nickerson DA,
    23. Abecasis G,
    24. Browning SR,
    25. Zöllner S,
    26. O’Connell JR,
    27. Mitchell BD, National Heart, Lung, and Blood Institute Trans-Omics for Precision Medicine (TOPMed) Consortium, TOPMed Population Genetics Working Group,
    28. O’Connor TD
    : De novo mutations across 1,465 diverse genomes reveal mutational insights and reductions in the Amish founder population. Proc Natl Acad Sci USA 117(5): 2560-2569, 2020. DOI: 10.1073/pnas.1902766117
    OpenUrlAbstract/FREE Full Text
  8. ↵
    1. Richards S,
    2. Aziz N,
    3. Bale S,
    4. Bick D,
    5. Das S,
    6. Gastier-Foster J,
    7. Grody WW,
    8. Hegde M,
    9. Lyon E,
    10. Spector E,
    11. Voelkerding K,
    12. Rehm HL, ACMG Laboratory Quality Assurance Committee
    : Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med 17(5): 405-424, 2015. DOI: 10.1038/gim.2015.30
    OpenUrlCrossRefPubMed
  9. ↵
    1. Lin L,
    2. Pan H,
    3. Qi Y,
    4. Ma Y,
    5. Qiu L
    : Reasons and resolutions for inconsistent variant interpretation. Hum Mut 2023: 1-11, 2023. DOI: 10.1155/2023/4955235
    OpenUrlCrossRef
  10. ↵
    1. Kim YE,
    2. Ki CS,
    3. Jang MA
    : Challenges and considerations in sequence variant interpretation for mendelian disorders. Ann Lab Med 39(5): 421-429, 2019. DOI: 10.3343/alm.2019.39.5.421
    OpenUrlCrossRefPubMed
  11. ↵
    1. Richards S,
    2. Aziz N,
    3. Bale S,
    4. Bick D,
    5. Das S,
    6. Gastier-Foster J,
    7. Grody WW,
    8. Hegde M,
    9. Lyon E,
    10. Spector E,
    11. Voelkerding K,
    12. Rehm HL, ACMG Laboratory Quality Assurance Committee
    : Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med 17(5): 405-424, 2015. DOI: 10.1038/gim.2015.30
    OpenUrlCrossRefPubMed
  12. ↵
    1. Carlson J,
    2. Locke AE,
    3. Flickinger M,
    4. Zawistowski M,
    5. Levy S,
    6. Myers RM,
    7. Boehnke M,
    8. Kang HM,
    9. Scott LJ,
    10. Li JZ,
    11. Zöllner S, BRIDGES Consortium
    : Extremely rare variants reveal patterns of germline mutation rate heterogeneity in humans. Nat Commun 9(1): 3753, 2018. DOI: 10.1038/s41467-018-05936-5
    OpenUrlCrossRefPubMed
PreviousNext
Back to top

In this issue

Anticancer Research: 44 (4)
Anticancer Research
Vol. 44, Issue 4
April 2024
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Back Matter (PDF)
  • Ed Board (PDF)
  • Front Matter (PDF)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Anticancer Research.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Novel Insights in Genetic Variant Classification
(Your Name) has sent you a message from Anticancer Research
(Your Name) thought you would like to see the Anticancer Research web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
8 + 0 =
Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.
Citation Tools
Novel Insights in Genetic Variant Classification
ANTHOULA CHATZIKYRIAKIDOU
Anticancer Research Apr 2024, 44 (4) 1799-1802; DOI: 10.21873/anticanres.16980

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Reprints and Permissions
Share
Novel Insights in Genetic Variant Classification
ANTHOULA CHATZIKYRIAKIDOU
Anticancer Research Apr 2024, 44 (4) 1799-1802; DOI: 10.21873/anticanres.16980
Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • Four Different Artificial Intelligence Models Versus Logistic Regression to Enhance the Diagnostic Accuracy of Fecal Immunochemical Test in the Detection of Colorectal Carcinoma in a Screening Setting
  • Google Scholar

More in this TOC Section

  • Glymphatic Insights in Glioblastoma
  • MAOA Inhibitor Plus Docetaxel in Patients Receiving and Progressing on Docetaxel Therapy
Show more Letter to the Editor

Similar Articles

Keywords

  • single nucleotide polymorphism
  • variant classification
  • pathogenic
  • VUS
  • benign
  • dominant
  • recessive
  • Genetic heterogeneity
  • incomplete penetrance
  • Mendelian inheritance
  • Complex inheritance
  • human disease
Anticancer Research

© 2025 Anticancer Research

Powered by HighWire